News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Johnson & Johnson Unit Needs More Inspection After Lapses Says FDA
May 26, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- The U.S. Food and Drug Administration is calling for further inspection and an outside audit of a Johnson & Johnson unit following manufacturing lapses.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Johnson & Johnson Family of Companies
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Gene editing
FDA Eyes Accelerated Reviews for Gene Editing Therapies
November 3, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Life-Threatening Liver Toxicity Triggers FDA Freeze on Two Intellia Gene Therapy Studies
October 30, 2025
·
2 min read
·
Tristan Manalac
Podcast
Novartis’ Big Buy, Q3 Earnings, Regeneron’s Dropped Cell Therapy, More
October 29, 2025
·
1 min read
·
Heather McKenzie
FDA
FDA Provides Guidance To Prevent Returned Applications, Aid Patient-Focused Drug Development
October 24, 2025
·
2 min read
·
Tristan Manalac